This activity was originally recorded on Tuesday, February 14, 2023. The activity EXPIRED on February 14, 2024, and is no longer available for CME credit, but the recording is still available for viewing.
About the Webinar 
Recent studies have shown that more than half of all U.S. physicians have experienced burnout, depression and anxiety during their careers. These symptoms were exacerbated by COVID-19, putting extraordinary strain on the healthcare workforce, causing physicians and other healthcare workers to experience unprecedented stressors which threaten not only their ability to practice safely, but also their well-being. While resources are available to support physicians experiencing burnout and other health issues, including substance use disorders and suicidal ideation, stigma persists about seeking treatment for fear it will adversely impact one’s ability to practice medicine. In response to this stigma, state medical boards have begun to examine the regulatory requirements that are seen as barriers to treatment seeking among licensees, including the requirement to disclose a history of treatment for health issues on licensing applications. Significant progress has been made by many state medical boards, but change to the licensing processes is still necessary in most jurisdictions to eliminate stigma and create a culture of well-being in the profession.
To capitalize on recent momentum in licensing application reform from state medical boards and engender further change, the FSMB has assembled experts from across the continuum to examine the issue of physician well-being in greater detail and discuss why it is of critical importance to the nation’s medical regulatory system. During this webinar, experts in licensing, policy development, physician health, and suicide prevention will share best practices in licensing, provide evidence-based strategies to remove barriers to well-being, and highlight supportive resources in hopes of catalyzing change across the profession, creating a culture of wellness, and ultimately reducing workforce stress and improving physician well-being.
About the Speakers
Joel T. Bundy, MD, FACP, FASN, FAAPL, CPE, is the Chief Quality and Safety Officer for Sentara Healthcare. Previously, he has served as Chief Medical Officer for both Sentara Leigh and Sentara CarePlex hospitals, and as a Nephrologist since 1994. He is passionate about quality and has completed a Master’s in Healthcare Quality and Safety Management through Jefferson University and is a Master Six Sigma Black Belt and Lean practitioner through training at Villanova University.
Dr. Bundy is also a Fellow of the American College of Physicians, the American Society of Nephrology, and the American Association for Physician Leadership, and is a Certified Physician Executive. He earned his medical degree from Wake Forest University. He completed his Internal Medicine residency and Nephrology fellowship through the University of Florida, University of California San Francisco, and the Naval Medical Center Portsmouth.
Kenneth E. Cleveland, MD, is the Executive Director of the Mississippi State Board of Medical Licensure. A native of Alabama, Dr. Cleveland completed his residency at the University of Mississippi Medical Center as Chief Surgical Resident in 2001. He since has practiced medicine in Mississippi in surgical and administrative capacities. He comes to the Mississippi Board of Medical Licensure from Remedy True Health, where he served as the owner, CEO and primary physician. His background brings a wealth of knowledge in both medicine and management.
J. Corey Feist, JD, MBA, is a health care executive with over 20 years of experience. Corey is the Co-Founder of the Dr. Lorna Breen Heroes’ Foundation and recently served as the Chief Executive Officer of the University of Virginia Physicians Group, the medical group practice of UVA Health comprised of 1200+ physicians and advanced practice providers. Corey also holds an adjunct faculty appointment at the UVA Darden School of Business where he recently taught a course entitled “Managing in a Pandemic: The Challenge of COVID-19″. He is also the Chair of the Board of the Charlottesville Free Clinic. Corey holds his Masters in Business Administration from the UVA Darden School of Business, his Juris Doctorate from Penn State Dickinson School of Law and his Bachelors degree from Hamilton College.
P. Bradley Hall, MD, DFASAM, is a third-generation West Virginia physician originally from Clarksburg, WV. He attended college, medical school and family practice residency at WV University. After 15-years of private practice in Bridgeport, WV, he became involved in the establishment of the WV Medical Professionals Health Program serving as the Founding Medical Director. Currently, Dr. Hall serves as Executive Medical Director of the WV Medical Professionals Health Program. He is also a board member and Past President of the Federation of State Physician Health Programs, where he served on numerous committees and is currently Co-Chair of the Accreditation Review Council in the establishment of the FSPHP’s Performance Enhancement and Effectiveness Review Program (PEER) for Physician Health Programs and treatment centers. Dr. Hall has served as President/Executive Director of the West Virginia Society of Addiction Medicine (WVSAM). He is a Distinguished Fellow of the American Society of Addiction Medicine and is a Diplomat of the American Board of Addiction Medicine. Additionally, Dr. Hall served on the Federation of State Medical Board's Impaired Physicians Committee in the updating of the Impaired Physicians Policy in 2012 and the 2021 update on the Federation of State Medical Board’s 2020 Workgroup updating the “Policy on Physician Illness and Impairment: Towards a Model that Optimizes Patient Safety and Physician Health”.
Laura Hoffman (she/her) serves as the Director of the Interactive Screening Program (ISP) for the American Foundation for Suicide Prevention (AFSP), where she has been on staff since 2011. Since 2014, she has overseen implementations of ISP at college and university campuses, hospitals and health systems and workplaces nationwide to connect over 200,000 people to available mental health services. She regularly speaks at national conferences as an expert on comprehensive suicide prevention strategies and programming for the health care workforce and college and university students.
Daniel Blaney-Koen, JD, is a senior attorney with the American Medical Association Advocacy Resource Center (ARC). The ARC attorneys focus on working with state and specialty medical societies on state legislative, regulatory and policy advocacy. The ARC also provides technical assistance and policy perspective with a wide range of national stakeholders such as the National Governors Association, National Association of Attorneys General, National Association of Insurance Commissioners and others. In addition to his work in the ARC, Daniel has held several roles at the AMA, including serving as a public information officer, policy analyst and speechwriter. Currently, Daniel focuses on state legislation and policy concerning the nation’s drug overdose epidemic, with particular emphasis on overdose prevention and treatment; treatment for patients with pain; and broad harm reduction efforts. Daniel also works on issues to support physicians and other health care professionals seeking care for mental health and wellness concerns; and he covers other pharmaceutical issues and related insurance market reforms. Daniel earned his Master of Fine Arts in Poetry from Colorado State University, and his Bachelor's Degree from the University of Arizona. He earned his law degree from the Loyola University Chicago School of Law.
About the Moderator
Mark L. Staz, MA, is Management Consultant for Regulatory Policy at the Federation of State Medical Boards. In his role, he is responsible for organizational initiatives related to regulatory best practices and supports the FSMB’s work in ethics and professionalism. He also supports the FSMB’s international collaborations with medical regulators outside of the United States, including its involvement in the International Association of Medical Regulatory Authorities. Mr. Staz has worked in medical regulation in Canada as a policy analyst for the College of Physicians and Surgeons of Ontario and has been involved in several policy and research initiatives addressing human resources for health, social determinants of health, and physician performance enhancement. He received his master’s degree in philosophy at York University and is currently writing his doctoral dissertation on conflicting rights in health policy.
Target Audience
This activity was designed specifically for physician and public members, as well as leadership staff of the state medical and osteopathic licensing boards, and others within the medical regulatory community.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
Accreditation Statement
The Federation of State Medical Boards is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statements
The Federation of State Medical Boards designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Federation of State Medical Boards certifies that non-physicians will receive an attendance certificate stating they participated in the activity that was designated for 1.5 AMA PRA Category 1 Credits™.
Disclosure Declaration
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. Conflict of interest statements were reviewed for all webinar planners and presenters. The following indicates the disclosure declaration information and the nature of those commercial interests.
All other speakers, course director, and planners at the Federation of State Medical Boards have no relevant financial interests to disclose.
Speaker Name
Name of Commercial Interest/Company
P. Bradley Hall, MD
Formal Advisor:Federation of State Physician Health Programs , Board Member (non-paid)
West Virginia Judicial & Lawyer Assistance Program, Board Member (non-paid)
West Virginia State Medical Board Trustee (non-paid)
System Requirements
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
Instructions for Participants and Obtaining CME Credit
There is no fee for this activity. To receive credit and receive their certificates, participants must view this CME activity in its entirety and complete the evaluation. The estimated time for completion of this activity is 1.5 hours.